Delphinus Medical Technologies

Delphinus Medical Technologies, LLC develops, commercializes, sells, and services the breast cancer screening solutions to hospitals and imaging clinics in the United States and internationally. It commercializes SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines women's breasts for the presence of benign and/or malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy. The company was founded in 2009 and is based in Detroit, Michigan.

Novi, US
50 (est)

Delphinus Medical Technologies Locations

Novi, US
Sunnyvale, US

Delphinus Medical Technologies Metrics

Delphinus Medical Technologies Summary

Founding Date


Total Funding

$58.5 M

Latest funding size

$39.5 M

Time since last funding

about 1 year


Beringea, Arboretum Ventures, North Coast Technology Investors, Beringea, Venture Investors, Arboretum Ventures, North Coast Technology Investors, Hopen Life Science Ventures, Waycross Ventures